15727078_lg

RESPONDING TO THE CORONAVIRUS PANDEMIC

 
 
Dear valued customer,
 
Current events around the coronavirus disease outbreak (COVID-19) are unfolding at an unprecedented pace.

At CELLnTEC we are evaluating the development daily. Leveraging business continuity programs, we remain dedicated to supplying our customers in all markets and providing scientific assistance and service excellence as usual.

At the same time, we have taken steps to ensure the safety of CELLnTEC staff.

Pharma.

CELLnTEC OPERATES ON REGULAR SCALE

 
CELLnTEC manufactures all products in Switzerland. Manufacturing and distribution of our products are operating on normal scale. Component and raw material stock levels continue to be fully satisfactory. We closely interact with our suppliers to steer forthcoming demands.
 

Normal supply to all markets and geographies

 
As a leading provider of precision cell culture media and products and as scientists ourselves, we understand the importance of uninterrupted supply also in the most difficult of times. We are committed to providing researchers and organizations with the necessary products, being it in basic, clinical or applied research.

We work hand in hand with our logistics partners and distributors to ensure successful supply to all geographies.
 

Scientific and Logistical Support

 
In case you have any scientific or logistical questions, please contact us or one of our distributor partners.
 
 
CELLnTEC Advanced Cell Systems

 
 

TOOLS FOR COVID-19 & RESPIRATORY DISEASES RESEARCH

 

CELLnTEC offers Airway Epithelial and Endothelial Media for developing 2D/3D cell culture systems and biological models
for investigating novel and recurring respiratory viruses